These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 7784960)
21. N-substituted phenyltropanes as in vivo binding ligands for rapid imaging studies of the dopamine transporter. Scheffel U; Lever JR; Abraham P; Parham KR; Mathews WB; Kopajtic T; Carroll FI; Kuhar MJ Synapse; 1997 Apr; 25(4):345-9. PubMed ID: 9097393 [TBL] [Abstract][Full Text] [Related]
22. Effect of the haloperidol tetrahydropyridine metabolite 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6- tetrahydropyridine on dopamine receptor and transporter binding. A nonhuman primate 123I-iodobenzamide and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane single photon emission computed tomographic study. Oliver DW; Dormehl IC; Van der Schyf CJ; Neumeyer JL; Hugo N; Keeve R; Rossouw NT; Müller-Gärtner HW; Castagnoli N Arzneimittelforschung; 1997 Jun; 47(6):692-9. PubMed ID: 9239444 [TBL] [Abstract][Full Text] [Related]
23. Distribution of cocaine recognition sites in rat brain: in vitro and ex vivo autoradiography with [125I]RTI-55. Fujita M; Shimada S; Fukuchi K; Tohyama M; Nishimura T J Chem Neuroanat; 1994 Jul; 7(1-2):13-23. PubMed ID: 7802967 [TBL] [Abstract][Full Text] [Related]
25. Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes. Silverthorn ML; Dersch CM; Baumann MH; Cadet JL; Partilla JS; Rice KC; Carroll FI; Becketts KM; Brockington A; Rothman RB J Pharmacol Exp Ther; 1995 Apr; 273(1):213-22. PubMed ID: 7714769 [TBL] [Abstract][Full Text] [Related]
26. PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain. Farde L; Halldin C; Müller L; Suhara T; Karlsson P; Hall H Synapse; 1994 Feb; 16(2):93-103. PubMed ID: 8197578 [TBL] [Abstract][Full Text] [Related]
27. Methyl 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditions. Laruelle M; Giddings SS; Zea-Ponce Y; Charney DS; Neumeyer JL; Baldwin RM; Innis RB J Neurochem; 1994 Mar; 62(3):978-86. PubMed ID: 8113817 [TBL] [Abstract][Full Text] [Related]
29. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter. Boja JW; Rahman MA; Philip A; Lewin AH; Carroll FI; Kuhar MJ Mol Pharmacol; 1991 Mar; 39(3):339-45. PubMed ID: 1826041 [TBL] [Abstract][Full Text] [Related]
30. Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys. Wilcox KM; Lindsey KP; Votaw JR; Goodman MM; Martarello L; Carroll FI; Howell LL Synapse; 2002 Jan; 43(1):78-85. PubMed ID: 11746736 [TBL] [Abstract][Full Text] [Related]
31. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428. Scheffel U; Pögün S; Stathis M; Boja JW; Kuhar MJ J Pharmacol Exp Ther; 1991 Jun; 257(3):954-8. PubMed ID: 2046028 [TBL] [Abstract][Full Text] [Related]
32. Binding of d-threo-[11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine. Gatley SJ; Ding YS; Volkow ND; Chen R; Sugano Y; Fowler JS Eur J Pharmacol; 1995 Aug; 281(2):141-9. PubMed ID: 7589201 [TBL] [Abstract][Full Text] [Related]
33. Characterization of the dopamine transporter in nonhuman primate brain: homogenate binding, whole body imaging, and ex vivo autoradiography using [125I] and [123I]IPCIT. al-Tikriti MS; Zea-Ponce Y; Baldwin RM; Zoghbi SS; Laruelle M; Seibyl JP; Giddings SS; Scanley BE; Charney DS; Hoffer PB Nucl Med Biol; 1995 Jul; 22(5):649-58. PubMed ID: 7581176 [TBL] [Abstract][Full Text] [Related]
34. Rate of binding of various inhibitors at the dopamine transporter in vivo. Stathis M; Scheffel U; Lever SZ; Boja JW; Carroll FI; Kuhar MJ Psychopharmacology (Berl); 1995 Jun; 119(4):376-84. PubMed ID: 7480516 [TBL] [Abstract][Full Text] [Related]
35. [11C]beta-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography. Halldin C; Farde L; Lundkvist C; Ginovart N; Nakashima Y; Karlsson P; Swahn CG Synapse; 1996 Apr; 22(4):386-90. PubMed ID: 8867033 [TBL] [Abstract][Full Text] [Related]
36. Direct approach for attenuating cocaine's effects on extracellular dopamine: targeting the dopamine transporter. Morgan AE; Porter SP; Clarkson FA; Volkow ND; Fowler JS; Dewey SL Synapse; 1997 Aug; 26(4):423-7. PubMed ID: 9215601 [TBL] [Abstract][Full Text] [Related]
37. Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects. Laruelle M; Wallace E; Seibyl JP; Baldwin RM; Zea-Ponce Y; Zoghbi SS; Neumeyer JL; Charney DS; Hoffer PB; Innis RB J Cereb Blood Flow Metab; 1994 Nov; 14(6):982-94. PubMed ID: 7929662 [TBL] [Abstract][Full Text] [Related]
38. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex. Boja JW; Carroll FI; Vaughan RA; Kopajtic T; Kuhar MJ Synapse; 1998 Sep; 30(1):9-17. PubMed ID: 9704876 [TBL] [Abstract][Full Text] [Related]
39. In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428. Wong DF; Yung B; Dannals RF; Shaya EK; Ravert HT; Chen CA; Chan B; Folio T; Scheffel U; Ricaurte GA Synapse; 1993 Oct; 15(2):130-42. PubMed ID: 8259524 [TBL] [Abstract][Full Text] [Related]
40. Novel 2-substituted cocaine analogs: binding properties at dopamine transport sites in rat striatum. Davies HM; Saikali E; Sexton T; Childers SR Eur J Pharmacol; 1993 Jan; 244(1):93-7. PubMed ID: 8420793 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]